Chemed (CHE) Q1 2026 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Chemed Corp (CHE)
Last chemed corp earnings: 4/28 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.chemed.com/investor-overview
Company Research
Source: Globe and Mail, The
President and Chief Executive Officer — Kevin J. McNamara Chief Financial Officer — Michael Witzeman President and Chief Executive Officer, VITAS HealthCare Corporation — Joel Wherley Takeaways VITAS Admissions -- 19,394 admissions, a 6.9% increase. Florida Combined Program Hospital Admission Mix -- 43.8% of total admissions from hospitals, within the 42%-45% stability range management targets. Admissions from Non-hospital Locations in Florida -- Increased 8.4% versus the prior year. Florida Medicare Cap Position -- Added $32.5 million to cap cushion; no Medicare cap billing limitation anticipated for the fiscal period. VITAS Net Revenue -- $420 million, a 3.1% increase. VITAS Adjusted EBITDA (Excluding Medicare Cap) -- $70.8 million, up 0.6%; margin at 16.8%. Average Daily Census (ADC) -- 22,723 patients, up 2.2%. Average Revenue Per Day -- $210.62, up 1.46 percentage points. Average Length of Stay -- 102.7 days, down from 118.7 days; median length of stay 15
Show less
Read more
Impact Snapshot
Event Time:
CHE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CHE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHE alerts
High impacting Chemed Corp news events
Weekly update
A roundup of the hottest topics
CHE
News
- Chemed (CHE) had its "sector perform" rating reaffirmed by Royal Bank Of Canada.MarketBeat
- A Look At Chemed (CHE) Valuation After Earnings Beat And VITAS Margin Strength [Yahoo! Finance]Yahoo! Finance
- Chemed Corp (CHE) Q1 2026 Earnings Call Highlights: Strong VITAS Performance Amid Roto-Rooter ... [Yahoo! Finance]Yahoo! Finance
- CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs [Yahoo! Finance]Yahoo! Finance
- Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
CHE
Earnings
- 4/23/26 - Beat
CHE
Sec Filings
- 4/28/26 - Form 10-Q
- 4/23/26 - Form 8-K
- 4/13/26 - Form 8-K
- CHE's page on the SEC website